Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,638.40 -31.32 -0.14%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: Tel Aviv
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

KMDA:IT

4,008.00 ILs 87.00 2.12%

As of 09:24:40 ET on 05/23/2013.

Company Profile for Kamada Ltd (KMDA)

Kamada is a biopharmaceutical company. The Company develops, produces, and markets specialty plasma therapeutics, specific and general immune globulins, and other prescribed medicines using chromatographic purification technology.

Contact Information

Kamada Ltd

Saphir Street 7
Nes Ziona, 74036
Israel
Phone: 972-08-940-6472
Fax: 972-08-940-6473

Key Executives for Kamada Ltd (KMDA)

Ralf HahnChairmanDavid TsurChief Executive Officer
Gil EfronChief Financial OfficerAvi BazizChief Operating Officer
Ruth WolfsonSenior VP:Quality & RegulationAmir YadlinVP:Human Resources
Drorit LevVP:Beit Kama QualityShabtai BauerVP:Research & Development
Pnina StraussDirector:Clinical ResearchLiat CohenController

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil